BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MLSC
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210429T183000
DTEND;TZID=America/New_York:20210429T193000
DTSTAMP:20260509T141914
CREATED:20210409T184926Z
LAST-MODIFIED:20210409T184926Z
UID:13689-1619721000-1619724600@www.masslifesciences.com
SUMMARY:A Conversation with the New MIT Koch Institute Director
DESCRIPTION:The Koch Institute at MIT celebrates the appointment of Matthew Vander Heiden as the fifth director of MIT’s NCI-designated cancer research program. A pioneer in cancer metabolism as well as a practicing oncologist\, Dr. Vander Heiden brings deep experience and keen insight to the multi-faceted work of the Koch Institute community. On Thursday\, April 29 he joins MIT President Emerita Susan Hockfield in a virtual conversation about his vision for cancer research at MIT. Register to receive Zoom information.
URL:https://www.masslifesciences.com/event/a-conversation-with-the-new-mit-koch-institute-director/
LOCATION:Online\, online
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210428T160000
DTEND;TZID=America/New_York:20210428T190000
DTSTAMP:20260509T141914
CREATED:20210409T185756Z
LAST-MODIFIED:20210409T185756Z
UID:13658-1619625600-1619636400@www.masslifesciences.com
SUMMARY:BioXchange Sponsored by Bailey Glasser
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. This month’s event will be sponsored by Bailey Glasser. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room.\n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform. \nMore about this month’s sponsor: \nBailey Glasser is a full service law firm with 15 offices throughout the country\, including in Boston. Clients rely on Bailey Glasser to handle the most challenging and consequential legal issues—regionally and nationwide. \nMedical device\, biotech\, pharmaceutical\, and other companies\, and their venture capital\, private equity and financing partners\, turn to Bailey Glasser’s multidisciplinary legal team for strategic legal counsel to help achieve their business objectives. Bailey Glasser’s broad range of innovative clients includes emerging startups\, mid-market companies and global corporations. \nBailey Glasser is also a litigation powerhouse. Its lawyers are equally comfortable and adept in the role of defendant and plaintiff. It brings a trial-focused approach to litigation to vigorously protect the interests of clients. Bailey Glasser represents government and businesses\, as well as individual plaintiffs and defendants\, and professionals and lawyers throughout the country call upon the firm to access its unique blend of resources and trial experience.
URL:https://www.masslifesciences.com/event/bioxchange-sponsored-by-bailey-glasser/
LOCATION:Online\, online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210421T120000
DTEND;TZID=America/New_York:20210421T130000
DTSTAMP:20260509T141914
CREATED:20210409T185310Z
LAST-MODIFIED:20210409T185310Z
UID:13682-1619006400-1619010000@www.masslifesciences.com
SUMMARY:Creating Confidence with Brenda Loan Baker
DESCRIPTION:In this webinar\, we’ll discuss how to appear credible and confident to significantly raise effectiveness! \nAbout this Event \nLife is rich and full! How does this work? By Creating Confidence! \nImagine how your life might change if you had the skills to show up at your best on purpose\, every time. Whether you are meeting one-on-one with clients\, interacting with colleagues\, or delivering a formal presentation\, appearing credible and confident will significantly raise your effectiveness. \n• Learn the power of executive presence \n• Recognize/Prevent the “tells” of nervousness and intimidation \n• Strike a balance between authority and approachability \n• Demonstrate composure under pressure \n*** \nJoin Brenda Loan Baker as she helps us explore ways to appear credible and confident to significantly raise our effectiveness!! \n*** \n*Donations will contribute toward the enrichment of women careers and future programs* \nThis webinar is for everyone interested\, register today! \n*** \nDate/Time: Wednesday\, April 21st\, 2021\, 12-1 PM \nLink to the webinar will be provided a day before the webinar. \n*** \nPCC Exective and Leadership Coach Brenda Loan Baker serves leaders at all levels and across a broad range of functional roles and industries. She has a special interest in partnering with women and minorities in normally male-dominated industries like STEM\, finance and law\, to help them become more confident\, visible\, and influential leaders. It is Brenda’s passion to assist women and minorities in building greater confidence\, improving their communication and public speaking\, so they can lead with strength and compassion and become a role model for women to follow. Leading them to dream bigger\, achieve their goals with or without a female mentor\, and blaze a path of leadership combining all of their qualities including the feminine one. \n*** \nCorporate Sponsorship opportunities are available. \nEmail info@womenaccelerators.org for more information. \n***
URL:https://www.masslifesciences.com/event/creating-confidence-with-brenda-loan-baker/
LOCATION:Online\, online
ORGANIZER;CN="Women Accelorators":MAILTO:info@womenaccelerators.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210417T133000
DTEND;TZID=America/New_York:20210417T143000
DTSTAMP:20260509T141914
CREATED:20210409T184336Z
LAST-MODIFIED:20210409T184336Z
UID:13692-1618666200-1618669800@www.masslifesciences.com
SUMMARY:MIT Koch Institute Virtual Tours
DESCRIPTION:Cambridge Science Fest 2021: MIT Koch Institute Tours \nWhile the MIT campus is closed\, hop on Zoom to enjoy behind the scenes tours of Koch Institute laboratories led by MIT scientists and engineers. Join researchers at the bench as you explore the tools and technologies of cutting-edge cancer research. Questions encouraged! Visit our webpage to register for some or all events and receive Zoom information. \nUpcoming Tours\nSaturday\, April 17 at 1:30 p.m. – Hemann Laboratory\, led by Kate Koch – explore the tools used to improve CAR-T immunotherapy \nWednesday\, April 21 at 10:00 a.m. – Hemann Laboratory\, led by Kate Koch – explore the tools used to improve CAR-T immunotherapy \nFriday\, April 23 at 12:30 p.m. – Bhatia Lab/Marble Center for Cancer Nanomedicine\, led by Liang Hao – explore nanotechnology for cancer therapeutics
URL:https://www.masslifesciences.com/event/mit-koch-institute-virtual-tours/2021-04-17/
LOCATION:Online\, online
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210415T100000
DTEND;TZID=America/New_York:20210415T110000
DTSTAMP:20260509T141914
CREATED:20210409T185358Z
LAST-MODIFIED:20210409T185358Z
UID:13679-1618480800-1618484400@www.masslifesciences.com
SUMMARY:Neurology Clinical Trials Are Failing. How Can We Fix Them?
DESCRIPTION:One billion people worldwide suffer from neurological related disorders with limited therapy options. Over 2000 neurological clinical trials start each year in the US alone. Yet\, it is estimated that only 5.9% of Phase I neurology drugs are likely to get FDA approval. \nResearch innovation such as new biomarkers or advanced algorithms often do not get translated into clinical practice\, slowing progress. Adding to that\, the scale\, inefficiency and subjectivity of neurological clinical trials makes them inherently difficult. Neuroimaging analysis is key to developing new therapies for brain disease but it’s difficult to do. \nJoin us for a discussion and audience Q&A hosted by QMENTA CEO\, Vesna Prčkovska. Hear from our esteemed panel of experts who work across the life sciences research\, development and care spectrum how clinical research leaders can take key steps now to transform the way they conduct neuroimaging based clinical trials to position them for success. Seats are limited so register now.
URL:https://www.masslifesciences.com/event/neurology-clinical-trials-are-failing-how-can-we-fix-them/
LOCATION:Zoom
ORGANIZER;CN="QMENTA":MAILTO:info@qmenta.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210413T083000
DTEND;TZID=America/New_York:20210413T094500
DTSTAMP:20260509T141914
CREATED:20210318T140830Z
LAST-MODIFIED:20210318T140852Z
UID:13565-1618302600-1618307100@www.masslifesciences.com
SUMMARY:Life Sciences & Sustainability: Exploring Opportunities with Alexandria Real Estate
DESCRIPTION:Scientific research is one of the greatest drivers of the Boston economy – and\, one of the greatest drivers of greenhouse gas emissions. How will laboratory buildings achieve net zero emissions without putting the squeeze on this critical economic engine? Alexandria Real Estate is often considered to be the gold standard for life science development. They are also setting the gold standard for ultra-low emissions laboratory buildings. How are they achieving this impressive goal? \nJoin the BSA\, Rick Malmstrom of Alexandria Real Estate and Jacob Knowles of BR+A for a Client Conversations exploration of their integrated design work that will achieve this goal\, focusing on the under construction\, 500\,000 GSF core-shell lab in Kendall Square that will approach fossil fuel free for space heating.
URL:https://www.masslifesciences.com/event/life-sciences-sustainability-exploring-opportunities-with-alexandria-real-estate/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210412T093000
DTEND;TZID=America/New_York:20210416T110000
DTSTAMP:20260509T141914
CREATED:20210409T185921Z
LAST-MODIFIED:20210409T185935Z
UID:13632-1618219800-1618570800@www.masslifesciences.com
SUMMARY:MassBioEd Career Exploration Week
DESCRIPTION:MassBioEd will be holding a series of 1-hour virtual Career Exploration events with five (5) different life sciences companies or academic institutions during the week of April 12th-16th. Each day\, students will have the chance to hear from professionals working in the industry and experience a virtual lab tour or lab demonstration. Participating companies include: Northeastern University\, MilliporeSigma\, Valo Health\, Arranta Bio\, and Thermo Fisher Scientific. Students\, educators and parents are all welcome to register! \nClick the registration link for more information regarding the event schedule. \nFor questions\, contact Kretsy Mondesir at Kretsy.mondesir@massbioed.org
URL:https://www.masslifesciences.com/event/massbioed-career-exploration-week/2021-04-12/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210409T140000
DTEND;TZID=America/New_York:20210409T160000
DTSTAMP:20260509T141914
CREATED:20210318T141207Z
LAST-MODIFIED:20210318T141207Z
UID:13566-1617976800-1617984000@www.masslifesciences.com
SUMMARY:Virtual Career Fair -Life Science Consortium North Shore
DESCRIPTION:The Life Science Consortium of the North Shore has convened a variety of life science companies ranging in size and technical disciplines\, all with facilities North of Boston. Students and alumnae of the Consortium schools will have the chance to learn about the participating companies from brief presentations on Zoom. Then students can select virtual networking breakout rooms to speak with employers that interest them. In these breakout rooms\, employers can connect with students regarding internship and job opportunities\, and answer questions about their company. This is a free event for both employers and students.
URL:https://www.masslifesciences.com/event/virtual-career-fair-life-science-consortium-north-shore/
LOCATION:Online\, online
ORGANIZER;CN="Life Science Consortium of the North Shore":MAILTO:lynn.sutherland@nsiv.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210408T173000
DTEND;TZID=America/New_York:20210408T190000
DTSTAMP:20260509T141914
CREATED:20210222T124313Z
LAST-MODIFIED:20210222T124313Z
UID:13388-1617903000-1617908400@www.masslifesciences.com
SUMMARY:Science Club for Girls - Virtual Catalyst Awards 2021
DESCRIPTION:Virtual Nonprofit Event\n100% of the proceeds from this event will be donated to Science Club for Girls \nJoin us for an inspiring evening where you’ll hear stories from our community\, see our Science Clubs ‘in action’\, and meet some remarkable women who are paving the way for a more diverse\, inclusive world of STEM. \n5:30 – 6:00 P.M. – Networking\n6:00 – 7:00 P.M. – Main event \nThis year\, we are excited to be honoring Beth Chandler\, CEO of YW Boston\, and Rana el Kaliouby\, Ph.D.\, CEO and Co-Founder of Affectiva as our Catalyst Awardees!
URL:https://www.masslifesciences.com/event/science-club-for-girls-virtual-catalyst-awards-2021/
LOCATION:Online\, online
ORGANIZER;CN="Science Club for Girls":MAILTO:scfg@scienceclubforgirls.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210406T120000
DTEND;TZID=America/New_York:20210406T124500
DTSTAMP:20260509T141914
CREATED:20210222T124407Z
LAST-MODIFIED:20210222T124407Z
UID:13387-1617710400-1617713100@www.masslifesciences.com
SUMMARY:Biopharma R&D During COVID-19: One Year Later
DESCRIPTION:The SARS-CoV-2 pandemic brought new challenges and opportunities to biotech and pharmaceutical companies. Several new vaccines and therapies have already been brought to patients. Companies initiated efforts to catalyze collaborative research\, new ways of working and social justice. One year into the pandemic\, we will examine the initial lessons for biopharma R&D – what worked\, what didn’t\, and how can the industry sustain momentum on emerging priorities for the future? Join Harvard Medical School Executive Education for a discussion with three of the industry’s top leaders. \nSpeakers: \nJay Bradner\, MD\nPresident\, Novartis Institutes for BioMedical Research (NIBR)\nExecutive Committee Member\, Novartis \nAndrew Plump\, MD\, PhD\nPresident\, Research & Development\, Takeda Pharmaceuticals \nMichelle McMurry-Heath\, MD\, PhD\nPresident & CEO\, Biotechnology Innovation Organization (BIO)
URL:https://www.masslifesciences.com/event/biopharma-rd-during-covid-19-one-year-later/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210405T150000
DTEND;TZID=America/New_York:20210409T173000
DTSTAMP:20260509T141914
CREATED:20210203T221220Z
LAST-MODIFIED:20210203T221220Z
UID:13188-1617634800-1617989400@www.masslifesciences.com
SUMMARY:Business of Biotech 201: From Molecule to Market\, R&D and Regulatory Considerations
DESCRIPTION:Discounts for MassBio Member Companies: MassBio Members receive discounts on all of our courses. Check here to see if your company is a MassBio Member. If so\, please contact courses@massbioed.org before registering to receive your coupon code. \nDescription \nThis MassBioEd online course builds on the business overview of “The Business of Biotech 101” course. For those considering careers in the biopharma space or transitioning from the science and technical aspects of the industry\, this course delivers an outline of Clinical\, Regulatory\, and Quality considerations and practices. Students will be provided foundational information about the BioPharma industry and regulations via instruction\, storytelling\, and breakout group discussions. Industry ethics will be discussed\, with emphasis on historical precedents. We will explore the decision-making process by touching on relevant topics such as market share and phases of development. \nGuest speakers will be invited to represent specific considerations and to showcase their roles and experiences. We will review Research and Development processes and considerations from pre-clinical through market approval. \nSchedule \nMonday\, April 5th\, 2021 03:00 PM – 05:30 PM EST\nWednesday\, April 7th\, 2021 03:00 PM – 05:30 PM EST\nFriday\, April 9th\, 2021 03:00 PM – 05:30 PM EST\nAgenda \nSession 1:\nThe History of Regulations\nIndustry Overview\nResearch & Development: An Overview of R&D \nSession 2:\nRoles in Clinical Trials\nMarketing Considerations \nSession 3:\nCompliance via Regulatory & Quality Processes
URL:https://www.masslifesciences.com/event/business-of-biotech-201-from-molecule-to-market-rd-and-regulatory-considerations/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210405T000000
DTEND;TZID=America/New_York:20210430T000000
DTSTAMP:20260509T141914
CREATED:20210127T191328Z
LAST-MODIFIED:20210127T191328Z
UID:13146-1617580800-1619740800@www.masslifesciences.com
SUMMARY:Driving Health Care Strategy in the COVID Era: Business Insights from Inside the Ecosystem
DESCRIPTION:A Harvard Medical School executive education program designed to provide a 360 degree immersion into the forces shaping health care. \nThe coronavirus pandemic has revealed many vulnerabilities within the global health care ecosystem. These challenges present opportunities for companies and health systems to create new value for health care. What strategies should you be developing for the COVID era? Whether you are a seasoned health care executive\, or a business leader looking to move into health care\, this program will prepare you to launch or advance initiatives that create new value in health care. \nHealth care is being transformed by several converging forces including the accelerating growth of machine learning\, genomics and precision medicine\, digital technologies\, changes in reimbursement and a renewed focus on the patient at the center of care. These forces will shape the challenges and opportunities for industry stakeholders across all health care sectors. In order for innovations to succeed and meet important unmet needs of patients\, providers or payers\, business and science leaders need an in-depth understanding of the current health care ecosystem.
URL:https://www.masslifesciences.com/event/driving-health-care-strategy-in-the-covid-era-business-insights-from-inside-the-ecosystem/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210331T120000
DTEND;TZID=America/New_York:20210331T133000
DTSTAMP:20260509T141914
CREATED:20210318T140429Z
LAST-MODIFIED:20210318T140429Z
UID:13570-1617192000-1617197400@www.masslifesciences.com
SUMMARY:How 3D Printing is Reshaping the Future of Health Tech
DESCRIPTION:3D printing has the potential to disrupt how innovators create and providers deliver healthcare solutions\, changing and impacting lives of patients. Join Johnson & Johnson Innovation – JLABS on 3/31 to hear from experts in the field on where they think the future of 3D printing is headed\, advancements that are on the horizon and the future of these printed healthcare solutions.
URL:https://www.masslifesciences.com/event/how-3d-printing-is-reshaping-the-future-of-health-tech/
LOCATION:Virtual Event
ORGANIZER;CN="Johnson & Johnson Innovation":MAILTO:clee22@its.jnj.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210330T093000
DTEND;TZID=America/New_York:20210330T103000
DTSTAMP:20260509T141914
CREATED:20210318T140535Z
LAST-MODIFIED:20210318T140535Z
UID:13567-1617096600-1617100200@www.masslifesciences.com
SUMMARY:Tufts Research Forums 2021: Successes and Challenges of the COVID-19 Vaccine Rollout in the Global Context
DESCRIPTION:Building on the themes that emerged from the Tufts 2020 COVID-19 Research Symposium: Research. Policy. Solutions\, the Office for the Vice Provost for Research will host a series of Research Forums this year. Curated by the COVID-19 Research Steering Committee\, these forums highlight Tufts’ unique niche in the research landscape and its ability to address issues in research equity and health to positively impact our local and global communities. The first topic of the series is Successes and Challenges of the COVID-19 Vaccine Rollout in the Global Context. \nThis event will explore critical issues related to the development and implementation of the COVID-19 vaccination program across the globe. After brief presentations\, the conversation will focus on how to ensure equitable access to the COVID-19 vaccine. \nThe expert panel will include Dr. Salim Abdool Karim\, FRS\, Director of the Centre for the AIDS Program of Research in South Africa\, and Dr. Ramanan Laxminaryanan\, Founder and Director of the Center for Disease Dynamics\, Economics & Policy\, presenting on India. The session will be moderated by Dr. Simone Wildes\, a Tufts Medical Center affiliated Infectious Disease Physician based out of South Shore Hospital and a member of the Massachusetts COVID-19 Vaccine Advisory Group. \nSponsored by the Office for the Vice Provost for Research. \nThis event is open to the public and registration is required. \nIf you have any questions\, please contact covid19research@tufts.edu.
URL:https://www.masslifesciences.com/event/tufts-research-forums-2021-successes-and-challenges-of-the-covid-19-vaccine-rollout-in-the-global-context/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210329T120000
DTEND;TZID=America/New_York:20210329T124500
DTSTAMP:20260509T141914
CREATED:20210222T124519Z
LAST-MODIFIED:20210222T124519Z
UID:13386-1617019200-1617021900@www.masslifesciences.com
SUMMARY:Health Care Leadership During COVID-19
DESCRIPTION:The COVID-19 pandemic has upended health care delivery and economics. This Harvard Medical School Executive Education webinar will provide the behind-the-scenes perspective of a senior hospital leader in a time of crisis. Dr. Kimball will discuss how she and her leadership team adapted to the immediate crisis as well as its prolonged evolution\, from establishing a command structure to discovering hidden talents on their team. The session will explore leadership lessons and her insights for the path forward.
URL:https://www.masslifesciences.com/event/health-care-leadership-during-covid-19/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210329T090000
DTEND;TZID=America/Los_Angeles:20210401T170000
DTSTAMP:20260509T141914
CREATED:20201215T182328Z
LAST-MODIFIED:20201215T182328Z
UID:12877-1617008400-1617296400@www.masslifesciences.com
SUMMARY:Festival of Biologics Usa
DESCRIPTION:The Festival of Biologics is the meeting place for the life science community to bridge the gap between academia and industry. With three events in one across Antibodies\, Immunotherapy and Biosimilars\, the Festival encourages conversation across the entire industry so you can inspire change\, champion innovation\, and address complex challenges that the industry is facing. \nOur mission is to bring together senior biologics professionals across the antibody\, immunotherapy\, and biosimilar value chains to showcase their research\, collaborate on challenges\, forge new connections and ultimately advance the industry to improve patient health.
URL:https://www.masslifesciences.com/event/festival-of-biologics-usa/
LOCATION:Online\, online
ORGANIZER;CN="Terrapinn":MAILTO:bree.vaughn@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210325T120000
DTEND;TZID=America/New_York:20210325T133000
DTSTAMP:20260509T141914
CREATED:20210304T023545Z
LAST-MODIFIED:20210304T023545Z
UID:13475-1616673600-1616679000@www.masslifesciences.com
SUMMARY:WIB-Greater Boston: Sixth Annual Lobster Pot Pitch Event
DESCRIPTION:What better way to honor Women’s History Month than to celebrate powerful women in the life sciences? Come to WIB-Greater Boston’s famous 6th Annual Lobster Pot. \nAs the name suggests\, this event will be in the “shark tank style\,” with each fundraising executive pitching to investors and the audience. The investors will provide feedback on the pitch and comment on the ideas presented. Join us on March 25\, 2021\, to learn how to pitch to investors more effectively\, and to check out some exciting NewCos in the life sciences space. \nSo whether you are starting your own company\, raising money\, or just want to celebrate powerful women\, this is one event that you can’t afford to miss. \nDisclaimer: This event may be recorded. There is a possibility your image and/or voice may be a part of that recording. If you are uncomfortable\, please be sure to turn off your webcam. \nProgram \n12:00 p.m. – 12:05 p.m. Welcome & Event Overview\n12:05 p.m. – 12:10 p.m. Panelist Introductions\n12:10 p.m. – 1:30 p.m. Company Pitches & Investor Feedback \n15 min each (6 min. pitches\, 6 min. feedback\, 1 min. transition\, 2 min. buffer) \n12:10 p.m. – 12:25 p.m. Company 1\n12:25 p.m. – 12:40 p.m. Company 2\n12:40 p.m. – 12:55 p.m. Company 3\n12:55 p.m. – 1:10 p.m. Company 3\n1:10 p.m. – 1:25 p.m. Panel Discussion\, Q&A\n1:25 p.m. – 1:30 p.m. Thanks and Closing Remarks \nSpeakers \nModerator \nMarian Nakada\, Ph.D.\, Vice President\, Venture Investments\, J&J Innovation JJDC \nVC panelists \nLaura Brass\, Ph.D.\, MBA\, Partner\, Novartis Venture Fund\nRuta Laukien\, Graybella Capital\nClaire Leurent\, Johnson & Johnson Innovation \nNewCo Pitches \nErika Smith\, CEO\, ReNetX Bio\, Inc\nElizabeth Gazda\, CEO\, Embrlabs\nMaria Luisa Pineda\, CEO & Co-Founder\, Envisagenics\nNatalie Artzi\, Ph.D. Co-Founder\, BioDevek \nPricing Information \nMembers: Free\nNon-members*: $10\nOptional Donation: $5
URL:https://www.masslifesciences.com/event/wib-greater-boston-sixth-annual-lobster-pot-pitch-event/
LOCATION:Online\, online
ORGANIZER;CN="Women in Bio":MAILTO:info@womeninbio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T170000
DTEND;TZID=America/New_York:20210324T233000
DTSTAMP:20260509T141914
CREATED:20210304T023414Z
LAST-MODIFIED:20210304T023420Z
UID:13485-1616605200-1616628600@www.masslifesciences.com
SUMMARY:2021 M2D2 $200K Challenge Pitch-Off & Awards Celebration
DESCRIPTION:Calling all Investors\, Medical Device Innovators\, Biotech Entrepreneurs\, Academics\, Students\, and Life Sciences Industry Professionals:\nJoin the worldwide life sciences community online as the $200K Challenge finalists selected through a competitive process pitch their innovations virtually to our panel of judges. At stake: a share of a $200\,000 purse of sponsor-provided\, in-kind resources that can help take an innovation to the next level—or even to market! \n(Examples of in-kind resources include lab space\, equipment\, and legal/regulatory guidance) \nWe’ve seen past winners advance to larger funding rounds\, commence clinical studies\, and enter strategic partnerships with global life sciences companies. The $200K Challenge is the place to see what’s up-and-coming in life sciences innovation. \nTICKETS ARE FREE—CHOOSE ONE OR BOTH EVENTS:\nFinalist Pitch-Off — Wednesday\, March 24th @ 5pm ET\nOur 15 Finalists will each have four minutes to make their cases to our panel. \nKEYNOTE SPEAKER: Kenn Turner\, President & CEO of Mass Life Sciences \nAwards Celebration — Wednesday\, April 7th @ 5pm ET\nJoin us for the announcement of the $200K Challenge winners! \nTHANK YOU TO OUR 2021 SPONSORS!
URL:https://www.masslifesciences.com/event/2021-m2d2-200k-challenge-pitch-off-awards-celebration/2021-03-24/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T160000
DTEND;TZID=America/New_York:20210324T190000
DTSTAMP:20260509T141914
CREATED:20210310T205507Z
LAST-MODIFIED:20210310T205507Z
UID:13517-1616601600-1616612400@www.masslifesciences.com
SUMMARY:BioXchange Sponsored by Pinnacle Technology Partners (PTP)
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. This month’s event will be sponsored by Pinnacle Technology Partners (PTP). \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the end time posted as the room will stay open as long as people are actively engaged within the chat room.\n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform. \nMore about this month’s sponsor: \nPTP architects\, implements and optimizes AWS technology solutions that enable life sciences organizations to develop faster\, lower IT costs\, and scale their operations. The AWS platform is trusted by the largest enterprises and the hottest startups alike to power a wide variety of workloads\, including web and mobile applications\, data analytics\, application development\, data processing\, warehousing\, storage\, archive and much more. \nWe are located in the Boston area\, the hub of some of the most innovative companies and research institutions in the world in the life sciences\, biotech\, biopharma and healthcare spaces. We work with companies from start-up to seed funding\, from public to pre-IPO\, to help them meet security compliance requirements (HIPAA\, GxP\, etc.)\, reduce infrastructure costs\, improve operational efficiencies\, and ultimately innovate faster. Working alongside their IT teams\, or directly with their scientists\, we design and deploy flexible infrastructure solutions on AWS.
URL:https://www.masslifesciences.com/event/bioxchange-sponsored-by-pinnacle-technology-partners-ptp/
LOCATION:Online\, online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T140000
DTEND;TZID=America/New_York:20210324T150000
DTSTAMP:20260509T141914
CREATED:20210318T140631Z
LAST-MODIFIED:20210318T140631Z
UID:13569-1616594400-1616598000@www.masslifesciences.com
SUMMARY:FDA and Emergency Use Authorization (EUA): Latest Updates for Startups.
DESCRIPTION:Alira Health and Mansfield Bio-Incubator present\, a U.S. Regulatory Update with Alira Health’s Mary McNamara-Cullinane\, Senior VP Regulatory \nAbout this Event \nJoin Alira Health’s Senior Vice President\, Regulatory Affairs\, Mary McNamara-Cullinane for a timely\, interactive event\, where Mary will give an update on the FDA\, including a walkthrough of the EUA process\, and best practices for submission development based on the latest FDA guidance. \nWho should attend: Entrepreneurs in biotech\, pharmaceuticals\, medical devices\, and other healthcare-related fields planning to approach FDA within the next year. Investors in these fields looking for guidance. \nThe presentation will be followed by a question-and-answer session.
URL:https://www.masslifesciences.com/event/fda-and-emergency-use-authorization-eua-latest-updates-for-startups-2/
LOCATION:Online\, online
ORGANIZER;CN="Mansfield Bio-Incubator":MAILTO:info@bioinc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T140000
DTEND;TZID=America/New_York:20210324T150000
DTSTAMP:20260509T141914
CREATED:20210310T205745Z
LAST-MODIFIED:20210310T205804Z
UID:13512-1616594400-1616598000@www.masslifesciences.com
SUMMARY:FDA and Emergency Use Authorization (EUA): Latest Updates for Startups.
DESCRIPTION:Alira Health and Mansfield Bio-Incubator present\, a U.S. Regulatory Update with Alira Health’s Mary McNamara-Cullinane\, Senior VP Regulatory \nAbout this Event \nJoin Alira Health’s Senior Vice President\, Regulatory Affairs\, Mary McNamara-Cullinane for a timely\, interactive event\, where Mary will give an update on the FDA\, including a walkthrough of the EUA process\, and best practices for submission development based on the latest FDA guidance. \nWho should attend: Entrepreneurs in biotech\, pharmaceuticals\, medical devices\, and other healthcare-related fields planning to approach FDA within the next year. Investors in these fields looking for guidance. \nThe presentation will be followed by a question-and-answer session.
URL:https://www.masslifesciences.com/event/fda-and-emergency-use-authorization-eua-latest-updates-for-startups/
LOCATION:Online\, online
ORGANIZER;CN="Mansfield Bio-Incubator":MAILTO:info@bioinc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210322T123000
DTEND;TZID=America/New_York:20210326T150000
DTSTAMP:20260509T141914
CREATED:20210203T224814Z
LAST-MODIFIED:20210203T224814Z
UID:13187-1616416200-1616770800@www.masslifesciences.com
SUMMARY:Business of Biotech 101
DESCRIPTION:Discounts for MassBio Member Companies: MassBio Members receive discounts on all of our courses. Check here to see if your company is a MassBio Member. If so\, please contact courses@massbioed.org before registering to receive your coupon code. \nDescription \nBusiness of Biotech 101 explores the business considerations that drive company strategies. Participants are provided with an overview of how the industry works\, why it works the way it does\, and how the industry may change in the years ahead. For those considering careers in the biopharma space or transitioning from the science and technical aspects of the industry to the business side\, this course delivers a sound\, basic understanding of the “business of biotech”. Students will be provided foundational information about the BioPharma industry and regulation via instruction\, storytelling\, and breakout group discussions. Industry ethics will be discussed\, with emphasis on historical precedents. We will explore the decision-making process by touching on relevant topics such as market share\, phases of development\, patient population\, and safety profile. Guest speakers will be invited to represent specific considerations and to showcase their roles and experiences. We will embark upon a high-level overview of Research and Development\, including pre-clinical through market approval. \nSchedule \nMonday\, March 22nd\, 2021 12:30 PM – 3:00 PM EST\nWednesday\, March 24th\, 2021 12:30 PM – 3:00 PM EST\nFriday\, March 26th\, 2021 12:30 PM – 3:00 PM EST\nAgenda \nSession 1:\nOrigins of the Biotech Industry: a Brief History\nAddressing Unmet Medical Need\nBiotechnology techniques used for therapeutics development\nBiotech Entrepreneurship\nBusiness Models of the Sector and Industries within \nSession 2:\nPreclinical\nClinical Development\nCreating Barriers to Entry: Market Exclusivity \nSession 3\nPatents\nEarly Stage Financing
URL:https://www.masslifesciences.com/event/business-of-biotech-101-2/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210320T183000
DTEND;TZID=America/New_York:20210320T203000
DTSTAMP:20260509T141914
CREATED:20210222T123213Z
LAST-MODIFIED:20210222T123513Z
UID:13390-1616265000-1616272200@www.masslifesciences.com
SUMMARY:2021 INSPIRE STEM Gala presented by NSBE Boston
DESCRIPTION:A virtual fundraising event to benefit STEM programs impacting Black Students. Stay IN for STEM with us on March 20. \n\n\n\n\nNSBE Boston Professionals invites you to our Annual INSPIRE STEM Scholarship Fundraiser & Awards gala on March 20th\, 2021. This year’s virtual event will benefit NSBE Boston’s year-round Youth STEM (science\, technology\, engineering & math) initiatives and also honor the accomplishments of Black leaders who are inspiring a generation of future black innovators. \nLive Entertainment | Auction | Trivia | Scholarship \nStay in for STEM! (we will reconvene again very soon!) \nDate: Saturday\, March 20th\, 2021 | Venue: Virtual Event \nDress code: No Rules! (this year we are having fun) \nBecome a sponsor – View sponsorship opportunities \nGala Honorees\nKenn Turner\, President & CEO\, Massachusetts Life Sciences Center \nEnna Jimenez\, Sr. Dir. & Head of Quality Assurance at IDEEMA \nFrederick M. Lowery\, Sr. VP & President\, Laboratory Products at ThermoFisher \nDr. Sara Suliman\, Immunologist & Research Scientist at Brigham and Women’s Hospital/Harvard Medical School \nH.G. Chissell\, Founder & CEO of Advanced Energy Group \nScholarship Award winners (TBA)\nThe 2021 NSBE Boston STEM Ambassador scholarships will be presented during this event. The STEM Ambassadors Scholarship program aims to support students who have shown academic excellence and are also committed to amplifying NSBE’s “Be 1 of 10\,000 Black Engineers” national initiative of increasing interest in STEM. \n– Apply for the 2021 NSBE Boston scholarships \nClick here to Support our STEM Initiatives.\nThis program is organized by NSBE Boston Professionals with the generous support of our members\, corporate partners and community of givers. Our vision is to continue to expand opportunities for Black students and professionals\, and also increase access to STEM resources in Boston’s under-served communities.
URL:https://www.masslifesciences.com/event/2021-inspire-stem-gala-presented-by-nsbe-boston/
LOCATION:Online\, online
ORGANIZER;CN="National Society of Black Engineers":MAILTO:membership@nsbeboston.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210319T180000
DTEND;TZID=America/New_York:20210319T193000
DTSTAMP:20260509T141914
CREATED:20210308T151414Z
LAST-MODIFIED:20210308T151414Z
UID:13518-1616176800-1616182200@www.masslifesciences.com
SUMMARY:Tips to Secure internships & scholarships in 2021
DESCRIPTION:STEAMid simplifies access to academic resources (internships\, scholarships & fellowships) nationwide. We primarily serve high school\, college\, and graduate students from underrepresented backgrounds to promote entry and success in all STEAM disciplines. \nThrough the upcoming webinar\, we aim to:\n(1) Expose students\, parents\, and educators to academic resources nationwide.\n(2) Cover the nuts & bolts of a strong application to improve a student’s odds of success.
URL:https://www.masslifesciences.com/event/tips-to-secure-internships-scholarships-in-2021/
LOCATION:Virtual Event
ORGANIZER;CN="STEAMid":MAILTO:roo@mysteamid.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210315T090000
DTEND;TZID=America/New_York:20210319T113000
DTSTAMP:20260509T141914
CREATED:20210203T225025Z
LAST-MODIFIED:20210203T225025Z
UID:13185-1615798800-1616153400@www.masslifesciences.com
SUMMARY:Science of Biotech 101
DESCRIPTION:Discounts for MassBio Member Companies: MassBio Members receive discounts on all of our courses. Check here to see if your company is a MassBio Member. If so\, please contact courses@massbioed.org before registering to receive your coupon code. \nDescription \nScience of Biotech 101 is designed for the non-scientist as a survey of the basic biological processes that are foundational to the biopharma and life sciences industry. You will apply your new understanding of basic cell and molecular biology to the work of most life sciences companies that research and develop therapies and products that improve lives\, enhance agriculture\, and decrease the dependence on fossil fuels. \nSchedule \nMonday\, March 15th\, 2021 9:00 – 11:30 AM\nWednesday\, March 17th\, 2021 9:00-11:30 AM\nFriday\, March 19th\, 2021 9:00-11:30 AM\nAgenda \nSession 1:\nIntroductions\nIndustry Overview\nThe Raw Materials of Biotechnology: Protein and Cells\nIndustry Applications: The Raw Materials of Biotechnology: DNA \nSession 2:\nMolecular Biology: From DNA to Protein\nGenetics: Chromosomes\, Genes and Genomes\nIndustry Applications \nSession 3:\nGenetic Engineering\nThe Immune System\nIndustry Applications: Mitigating Disease
URL:https://www.masslifesciences.com/event/science-of-biotech-101/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210312T110000
DTEND;TZID=America/New_York:20210312T130000
DTSTAMP:20260509T141914
CREATED:20210304T023143Z
LAST-MODIFIED:20210304T023143Z
UID:13488-1615546800-1615554000@www.masslifesciences.com
SUMMARY:BARDA Vaccines against Anti-Microbial Resistance (AMR) Workshop
DESCRIPTION:Are you working to develop a vaccine against E. coli (urinary)\, Klebsiella pneumoniae\, Pseudomonas aeruginosa\, or Staphylococcus aureus? \nCompanies and others interested in working with BARDA on AMR are encouraged to attend. The event is open to the public\, but space is limited. Be sure to register by March 5\, 2021. Please\, no more than four people from one organization. \nOne-on-One Meetings: Are you a product developer working on a vaccine against one of the four targeted pathogens (listed on the website link below)? Be sure to request a private meeting when you register for the workshop.
URL:https://www.masslifesciences.com/event/barda-vaccines-against-anti-microbial-resistance-amr-workshop/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210310T100000
DTEND;TZID=America/New_York:20210310T113000
DTSTAMP:20260509T141914
CREATED:20201124T161339Z
LAST-MODIFIED:20201124T161555Z
UID:12769-1615370400-1615375800@www.masslifesciences.com
SUMMARY:Panel 4: New Pathways for a Data Science Workforce
DESCRIPTION:Panel 4 Guiding Question: ​\nHow might EDC’s expertise in developing and implementing ​HS and CC data science initiatives form a key element of ​a sustained\, multi-year effort to grow\, in collaboration with others\, the size and diversity of the state’s future data science workforce?​ \nPanelist\nModerator\, Sarita Pillai\, EDC\nMichael Harris\, Bunker Hill Community College\nRandy Kochevar\, EDC\nRebecca Lewis\, EDC\nJoyce Malyn-Smith\, EDC \nExpanding Access to Data Science Careers\nEach discussion in the panel series will address a key component critical to the development of a strategic plan to extend and expand the early-stage Data Science pipeline: \n\nTo understand the need for a career pathway that begins with high school and community college students.\nTo review existing policies in Massachusetts that support efforts to prepare more students for Data Science careers\, and discuss what additional policy support might be needed.\nTo learn from programs that broaden participation in other disciplines and apply those best practices in developing outreach and support programs for a more diverse community of students.\nTo discover current initiatives for high school and community college students and discuss how they may form the basis of the early-stage Data Science pipeline.
URL:https://www.masslifesciences.com/event/panel-4-new-pathways-for-a-data-science-workforce-new-pathways-for-a-data-science-workforce%e2%80%8b/
LOCATION:Online\, online
ORGANIZER;CN="Education Development Center":MAILTO:datascience@edc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210309T140000
DTEND;TZID=America/New_York:20210309T153000
DTSTAMP:20260509T141914
CREATED:20210304T023227Z
LAST-MODIFIED:20210304T023227Z
UID:13487-1615298400-1615303800@www.masslifesciences.com
SUMMARY:Webinar: Incubating and Launching New Life Sciences Companies
DESCRIPTION:This 90-minute webinar will explore the processes\, considerations\, and other factors behind the incubation and launch of new companies by some of today’s leading venture capital firms. We’ll address the following key questions and topics: \nWhat are common sources of ideas for new companies and how do VC business models facilitate and measure the progress and de-risking of translational science?\nHow do venture firms approach financing a new entity and how do they balance capital at risk and value capture with syndication and/or non-dilutive funding from partnerships?\nWhat are venture firms’ views on founder equity for inventors\, for initial key team members\, and for their own firms in their capacity as new company founders?\nWhat are key steps to creating an ideal initial management team? \nWhen \nTuesday\, March 9\, 2021\n2:00 – 3:30 pm ET // 11:00 am – 12:30 pm PT \nThis is an online event.
URL:https://www.masslifesciences.com/event/webinar-incubating-and-launching-new-life-sciences-companies/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210309T100000
DTEND;TZID=America/New_York:20210309T110000
DTSTAMP:20260509T141914
CREATED:20210222T124122Z
LAST-MODIFIED:20210222T124122Z
UID:13366-1615284000-1615287600@www.masslifesciences.com
SUMMARY:Turbo-charging Neurology Research into Clinical Practice - WEBINAR
DESCRIPTION:Translation of neurology research advances into clinical practice is challenged by the difficulty of compliantly collecting\, calibrating and processing large scale brain image and related data to derive patient insights. \nDuring this webinar\, an esteemed panel of neurology key opinion leaders and innovators will discuss how neurology researchers\, AI-tool developers and innovative technology companies can collaborate to turbo-charge the transfer of brain research into clinical practice.
URL:https://www.masslifesciences.com/event/turbo-charging-neurology-research-into-clinical-practice-webinar/
ORGANIZER;CN="QMENTA":MAILTO:info@qmenta.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210309T093000
DTEND;TZID=Europe/London:20210310T173000
DTSTAMP:20260509T141914
CREATED:20210111T214433Z
LAST-MODIFIED:20210111T214433Z
UID:12926-1615282200-1615397400@www.masslifesciences.com
SUMMARY:3rd Annual Pharma Supply-Chain & Security World 2021 “Supply-Chain\, Drug Serialization and Anti-Counterfeiting” Virtual Conference and Expo
DESCRIPTION:The Annual Pharma Supply Chain and Security World Summit is now online\, and this time with more focus on optimizing your supply chain challenges to ensure an agile\, responsive\, streamlined and secured supply chain in Global platform. Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit\, diverted\, and adulterated drugs entering into the supply chain. Apart from having an end to end visibility and traceability within the supply chain\, an effective serialization programs will be a key differentiator and will be a competitive advantage for the pharmaceutical companies. Drug counterfeiting which is not only a global public health risk\, but also harm the quality of the product\, the integrity of the brand\, the economy and even national security. Revenues from the pharma and bio-pharma counterfeit market is estimated to be more than $200 billion. Aligning your anti-counterfeiting strategy with the corporate supply chain strategy should plot a roadmap for implementing anti-counterfeiting measures. \nBoth industry and governments across the world recognising the importance of implementing product serialization\, it becomes obligatory for all entities within the supply chain to comply with federal or state legislations pertaining to the locations in which they operate \nInitiatives focusing on supply chain monitoring\, such as mass serialisation\, track and trace or hologram tagging\, had mixed outcomes\, as counterfeiters are agile and have found ways to bypass the steps quickly. Pharmaceutical companies and regulators are still developing techniques to stop them by creating intelligence led brand protection strategy. This also reveals numerous gaps in the governmental and industry efforts to safeguard global pharmaceutical and bio-tech supplies. \nCorvus Global Events invites you to Pharma Supply Chain & Security World 2021 – Supply-chain\, Drug Serialization And Anti-Counterfeiting virtual conference\, which will have Pharma industry experts sharing various challenges faced\, new strategies\, case studies and use of innovative ideas\, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference you’ll not only discover innovative technologies\, transformation strategies and collaboration methods\, but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting. \nIt gives us a great pleasure to welcoming you to the 3rd Annual Pharma Supply Chain & Security World 2021. \nKey Highlights \n• Streamlining your supply chain\n• End to End supply chain\n• Designing an optimal supply chain network\n• Developing a sustainable Serialization strategy\n• Integration of track & trace solutions in production and supply chain\n• Smart Packaging\, Labelling\, Artwork\, Warehouse & Logistics\n• Serialization Data and Analytics driven approach to increase supply chain agility\n• Adoption of Blockchain in pharma supply chain\n• Brand Protection & Securing supply chain integrity\n• Global enterprise level solutions for anti-counterfeiting\n• Tackling pharmaceutical crime – initiatives at multinational\, EU and national level\n• IP and regulatory enforcement\n• Synchrony of the Pharma Industry and professional bodies against counterfeiting\n• Understanding and meeting the needs of DSCSA\, EU FMD and other global regulations\n• Strategies for public awareness and patient protection\n• Best practices to protect your brand\n• The role of the Internet in aiding the counterfeiters – How to overcome the situation?\n• Effective Authentication Technologies\n• Best selection of tamper-evident features\n• Developing a RMP for your supply chain to protect your Brand\, Product and Patient Safety\n• The need to understand and adopt new technologies like IoT\, Analytics\, Blockchain\, Machine Learning and Artificial Intelligence\n• Case study: How companies are structuring their counterfeiting efforts and departments? \nWho should attend the conference? \nAttendees include GMs\, VPs\, Directors\, Heads and Managers of: \n• Pharmaceutical manufacturers and distributors\n• Supply Chain management companies\n• Healthcare professionals\n• Pharmacists\n• Serialization\, Track and Trace solution providers\n• Brand protection\, enforcement\, security\, integrity and management companies\n• Healthcare research organizations\n• Pharmaceutical industry professional associations\n• Anti-counterfeiting organizations\n• Packaging & labelling companies\n• Authentication technology suppliers\n• Contract manufacturing organization (CMO)\n• IT service providers\n• Intellectual Property\, investigators and Trademark council\n• Drug regulatory agencies and customs
URL:https://www.masslifesciences.com/event/3rd-annual-pharma-supply-chain-security-world-2021-supply-chain-drug-serialization-and-anti-counterfeiting-virtual-conference-and-expo/
LOCATION:Online\, online
ORGANIZER;CN="corvus global events":MAILTO:info@corvusglobalevents.com
END:VEVENT
END:VCALENDAR